Free-cash-flow proxy decreased 9.5%
Free-cash-flow proxy changed -9.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.4B→$1.2B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SYK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 356 bp lower
Free-cash-flow margin changed -356 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
22.34%→18.77%2 prior comparisons
Operating cash-flow margin moved 302 bp lower
Operating cash-flow margin changed -302 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
25.43%→22.41%2 prior comparisons
Receivables / revenue moved 350 bp lower
Receivables / revenue changed -350 basis points from the comparable as-filed period.
60.15%→56.64%2 prior comparisons
Working capital increased 22.0%
Working capital changed +22.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$6.3B→$7.7B4 prior comparisons
Revenue increased 7.6%
Revenue changed +7.6% from the comparable as-filed period.
$6.1B→$6.5B2 prior comparisons
Inventory increased 7.0%
Inventory changed +7.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$5.4B→$5.7B4 prior comparisons
Operating cash flow decreased 5.1%
Operating cash flow changed -5.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.5B→$1.5B2 prior comparisons
Capital expenditure increased 26.7%
Capital expenditure changed +26.7% from the comparable as-filed period.
$187.0M→$237.0M2 prior comparisons
Working capital / assets moved 288 bp higher
Working capital / assets changed +288 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
13.38%→16.26%4 prior comparisons
Operating income decreased 8.9%
Operating income changed -8.9% from the comparable as-filed period.
$1.1B→$1.0B2 prior comparisons
Net income decreased 12.3%
Net income changed -12.3% from the comparable as-filed period.
$859.0M→$753.0M2 prior comparisons
Stockholders' equity increased 7.7%
Stockholders' equity changed +7.7% from the comparable as-filed period.
$21.8B→$23.5B2 prior comparisons
Gross profit increased 10.3%
Gross profit changed +10.3% from the comparable as-filed period.
$3.9B→$4.2B2 prior comparisons
Selling, general & administrative increased 13.1%
Selling, general & administrative changed +13.1% from the comparable as-filed period.
$2.0B→$2.3B2 prior comparisons
Current ratio increased 18.0%
Current ratio changed +18.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.85→2.184 prior comparisons
Noncurrent long-term debt decreased 4.5%
Noncurrent long-term debt changed -4.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$14.8B→$14.2B4 prior comparisons
Capex / revenue moved 55 bp higher
Capex / revenue changed +55 basis points from the comparable as-filed period.
3.09%→3.63%2 prior comparisons
Research & development increased 5.6%
Research & development changed +5.6% from the comparable as-filed period.
$410.0M→$433.0M2 prior comparisons
Inventory / revenue moved 51 bp lower
Inventory / revenue changed -51 basis points from the comparable as-filed period.
88.66%→88.14%2 prior comparisons
Current assets increased 3.4%
Current assets changed +3.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$13.7B→$14.2B4 prior comparisons
Operating cash flow / net income increased 8.2%
Operating cash flow / net income changed +8.2% from the comparable as-filed period.
1.79→1.942 prior comparisons
Stock-based compensation increased 8.1%
Stock-based compensation changed +8.1% from the comparable as-filed period.
$62.0M→$67.0M2 prior comparisons
Cost of revenue increased 3.0%
Cost of revenue changed +3.0% from the comparable as-filed period.
$2.2B→$2.3B2 prior comparisons
Cash & equivalents increased 0.5%
Cash & equivalents changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.3B→$3.3B4 prior comparisons
Total assets increased 0.4%
Total assets changed +0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$47.1B→$47.2B4 prior comparisons
SBC / revenue moved 0 bp higher
SBC / revenue changed +0 basis points from the comparable as-filed period.
1.02%→1.03%2 prior comparisons
R&D / revenue moved 13 bp lower
R&D / revenue changed -13 basis points from the comparable as-filed period.
6.77%→6.64%2 prior comparisons
Trade receivables increased 1.4%
Trade receivables changed +1.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$3.6B→$3.7B4 prior comparisons
Free-cash-flow proxy increased 14.1%
Free-cash-flow proxy changed +14.1% from the comparable as-filed period.
$928.0M→$1.1B3 prior comparisons
Inventory / revenue moved 404 bp lower
Inventory / revenue changed -404 basis points from the comparable as-filed period.
87.83%→83.79%2 prior comparisons
Operating cash flow increased 13.5%
Operating cash flow changed +13.5% from the comparable as-filed period.
$1.1B→$1.3B3 prior comparisons
Revenue increased 9.4%
Revenue changed +9.4% from the comparable as-filed period.
$6.0B→$6.6B2 prior comparisons
Receivables / revenue moved 825 bp lower
Receivables / revenue changed -825 basis points from the comparable as-filed period.
65.06%→56.81%2 prior comparisons
Working capital / assets moved 380 bp higher
Working capital / assets changed +380 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
12.34%→16.14%4 prior comparisons
Current liabilities decreased 8.3%
Current liabilities changed -8.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$7.3B→$6.7B4 prior comparisons
Gross profit increased 17.1%
Gross profit changed +17.1% from the comparable as-filed period.
$3.8B→$4.5B2 prior comparisons
Stockholders' equity increased 13.2%
Stockholders' equity changed +13.2% from the comparable as-filed period.
$21.2B→$24.0B2 prior comparisons
Operating cash flow / net income decreased 21.4%
Operating cash flow / net income changed -21.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.26→0.992 prior comparisons
Current assets increased 10.9%
Current assets changed +10.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$13.0B→$14.4B4 prior comparisons
Current ratio increased 20.9%
Current ratio changed +20.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.78→2.164 prior comparisons
Total assets increased 3.5%
Total assets changed +3.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$46.3B→$47.9B4 prior comparisons
Research & development increased 6.6%
Research & development changed +6.6% from the comparable as-filed period.
$407.0M→$434.0M2 prior comparisons
Shares outstanding increased 0.3%
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
382,307,298→383,573,0468 prior comparisons
Selling, general & administrative increased 7.2%
Selling, general & administrative changed +7.2% from the comparable as-filed period.
$2.1B→$2.2B2 prior comparisons
Cost of revenue decreased 4.1%
Cost of revenue changed -4.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.2B→$2.1B2 prior comparisons
Capital expenditure increased 10.4%
Capital expenditure changed +10.4% from the comparable as-filed period.
$183.0M→$202.0M3 prior comparisons
Stock-based compensation increased 10.2%
Stock-based compensation changed +10.2% from the comparable as-filed period.
$49.0M→$54.0M3 prior comparisons
Inventory increased 4.4%
Inventory changed +4.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.3B→$5.5B4 prior comparisons
Noncurrent long-term debt decreased 4.3%
Noncurrent long-term debt changed -4.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$14.8B→$14.2B4 prior comparisons
Operating cash-flow margin moved 69 bp higher
Operating cash-flow margin changed +69 basis points from the comparable as-filed period.
18.45%→19.14%2 prior comparisons
Free-cash-flow margin moved 66 bp higher
Free-cash-flow margin changed +66 basis points from the comparable as-filed period.
15.41%→16.07%2 prior comparisons
Capex / revenue moved 3 bp higher
Capex / revenue changed +3 basis points from the comparable as-filed period.
3.04%→3.07%2 prior comparisons
Trade receivables decreased 4.5%
Trade receivables changed -4.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$3.9B→$3.7B4 prior comparisons
SBC / revenue moved 1 bp higher
SBC / revenue changed +1 basis points from the comparable as-filed period.
0.81%→0.82%2 prior comparisons
R&D / revenue moved 17 bp lower
R&D / revenue changed -17 basis points from the comparable as-filed period.
6.76%→6.59%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.